Compare AbCellera Biologics Inc (ABCL) vs Check Point Software Technologies Ltd (CHKP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Check Point Software Technologies Ltd — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Check Point Software Technologies Ltd trades at $129.01 (market cap $13.18B). The key difference: Check Point Software Technologies Ltd is far larger — about 4.4× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Check Point Software Technologies Ltd nearer its low. Which is the better fit depends on your goals.
| ABCL | CHKP | |
|---|---|---|
Market Cap | $2.99B | $13.18B |
Sector | Health | Technology |
52-Week High | $9.76 | $206.91 |
52-Week Low | $2.78 | $112.47 |
Enterprise Value | $2.58B | $12.88B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Check Point Software Technologies Ltd
Check Point is a global leader in cybersecurity solutions. It provides comprehensive protection against advanced cyber threats for corporate networks, cloud environments, mobile devices, and critical infrastructure.
Read more on CHKP →
